We strongly believe in supporting the community.
We work closely with patient associations, as our goal is to improve the health of Canadians living with diseases. AbbVie is fully committed to upholding the highest ethical standards regarding patient association funding, and our current process meets these standards.
We also follow the Innovative Medicine Canada (IMC) Code of ethical practices. To learn more, we encourage you to visit section 3.3 - Guidelines for transparency in funding of patient and advocacy groups and patient associations (including annex A) from the 2022 Code of Ethical Practices document listed on the Innovative Medicines Canada Web site.
Some patient associations that receive support from AbbVie include:
You will be leaving your country’s AbbVie site and will be redirected to another country’s website. The AbbVie’s web site to where you will be redirected is exclusively designed for residents of particularly one or various countries, as announced in such web site. As a result, the website where you will be directed may contain pharmaceutical products information or other information that is not approved in other countries, regions or even in your country or territory of reference. If you live in a country other than those to which the site is directed, please contact your local AbbVie affiliate for the correct information on the products of your country of residence.